Cellular and molecular properties associated with osteosarcoma cells

被引:46
作者
Benayahu, D [1 ]
Shur, I
Marom, R
Meller, I
Issakov, J
机构
[1] Tel Aviv Univ, Sackler Sch Med, Dept Cell Biol & Histol, IL-66978 Tel Aviv, Israel
[2] Sourasky Med Ctr, Dept Orthoped Oncol, Tel Aviv, Israel
[3] Sourasky Med Ctr, Dept Pathol, Tel Aviv, Israel
关键词
osteosarcoma; cell surface markers; gene expression; biglycan;
D O I
10.1002/jcb.1270
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Osteosarcoma cells are recognized by abnormal function that causes a primary bone tumor. Osteosarcoma cells U2OS and SAOS-2 were analyzed for the expression of cell surface markers. High expression was quantified for hyaloronidase receptor (CD-44) > moderate for integrins (CD-51 and -61), > and lower for selectins (CD-62). High mitotic capacity were demonstrated by gene expression (measured by RT-PCR) and the protein level (measured by FACS) for JOS, cMYC, and cJUN. The basic definition of osteosarcoma is excessive production oft pathological osteoid. Expression of mRNA for matrix genes osteocalcin, osteonectin, and biglycan was studied. Osteocalcin and osteonectin were detected in RNA from primary cultured marrow stromal, trabecular bone cells, and osteosarcoma cell lines (U2OS, SAOS-2). mRNA for biglycan was detected only in primary cells and MG-63 cell line and was undetectable in RNA from U,OS, SAOS-2 osteosarcoma cell lines and by RNA extracted from bone biopsies of osteosarcoma patients. The absence of biglycan message observed in osteosarcoma samples provides evidence for the alterations in the extra cellular matrix which result with non-mineralized osteoid produced by the osteosarcoma cells. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:108 / 114
页数:7
相关论文
共 23 条
[1]   BONE-RELATED MATRIX PROTEINS EXPRESSION IN-VITRO AND IN-VIVO BY MARROW STROMAL CELL-LINE [J].
BENAYAHU, D ;
GUREVITZ, OA ;
SHAMAY, A .
TISSUE & CELL, 1994, 26 (05) :661-666
[2]   BONE-MARROW INTERFACE - PREFERENTIAL ATTACHMENT OF AN OSTEOBLASTIC MARROW STROMAL CELL LINE [J].
BENAYAHU, D ;
FRIED, A ;
EFRATY, M ;
ROBEY, PG ;
WIENTROUB, S .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, 59 (02) :151-160
[3]   Extracellular matrix-integrin interactions in osteoblast function and tissue remodeling [J].
Damsky, CH .
BONE, 1999, 25 (01) :95-96
[4]  
FISHER LW, 1989, J BIOL CHEM, V264, P4571
[5]  
Fried A, 1996, J CELL BIOCHEM, V61, P246
[6]  
Globus RK, 1998, J CELL SCI, V111, P1385
[7]   BONE-MATRIX RGD GLYCOPROTEINS - IMMUNOLOCALIZATION AND INTERACTION WITH HUMAN PRIMARY OSTEOBLASTIC BONE-CELLS IN-VITRO [J].
GRZESIK, WJ ;
ROBEY, PG .
JOURNAL OF BONE AND MINERAL RESEARCH, 1994, 9 (04) :487-496
[8]   HUMAN OSTEOBLAST-LIKE CELLS RESPOND TO MECHANICAL STRAIN WITH INCREASED BONE-MATRIX PROTEIN-PRODUCTION INDEPENDENT OF HORMONAL-REGULATION [J].
HARTER, LV ;
HRUSKA, KA ;
DUNCAN, RL .
ENDOCRINOLOGY, 1995, 136 (02) :528-535
[9]  
JUKKOLA A, 1993, J BONE MINER RES, V8, P651
[10]   Overexpression of matrix metalloproteinase (MMP)-9 correlates with metastatic potency of spontaneous and 4-hydroxyaminoquinoline 1-oxide (4-HAQO)-induced transplantable osteosarcomas in rats [J].
Kido, A ;
Tsutsumi, M ;
Iki, K ;
Takahama, M ;
Tsujiuchi, T ;
Morishita, T ;
Tamai, S ;
Konishi, Y .
CANCER LETTERS, 1999, 137 (02) :209-216